Although elevated peripheral S100β levels are not always determinative of blood-brain barrier break-down [75], the lack of change in S100β between control and ALS sera indicates that CNS proteins in these donors remain partitioned from the periphery. The gene discussed is S100B; the disease is amyotrophic lateral sclerosis.